513 (Meloxicam 15 mg)

Pill with imprint 513 is Yellow, Elliptical/Oval and has been identified as Meloxicam 15 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Meloxicam is used in the treatment of osteoarthritis; juvenile rheumatoid arthritis; rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 513

Meloxicam

Imprint: 513
Strength: 15 mg
Color: Yellow
Size: 11.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Nonsteroidal anti-inflammatory drugs
Pregnancy Category: C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule: Not a controlled drug
Labeler / Supplier: Caraco Pharmaceutical Laboratories
National Drug Code (NDC): 57664-0513